Healthcare M&A Advisory Pharmaceutical

M&A Advisory

Lazard

Full Credential Description

GW Pharmaceuticals. United Kingdom. Announced Date 01/05/2013. Closed Date 07/05/2013. Deal value: $31m. U.S. initial public offering. Industry: GW Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of cannabinoid-based medicines.

Back to Search Contact Business